News

Samsung Biologics Labor and Management to Resume Negotiations Next Month; Union Threatens Strike If Talks Fail

Samsung Biologics Labor and Management to Resume Negotiations Next Month; Union Threatens Strike If Talks Fail
▲ Samsung Biologics

Labor and management at Samsung Biologics, who have been at odds over wage increases and the improvement of personnel systems, will resume additional negotiations starting on the 3rd of next month.

The union has defined these upcoming negotiations as "all-or-nothing talks" and stated its policy to sequentially launch a strike if they ultimately break down.

The Samsung Biologics labor union announced today (the 28th), "The negotiation schedule is set to begin on November 3," adding, "Under the premise that the negotiations could be extended, both labor and management have decided to clear their schedules for the entire first week of November."

The union added, "We set the schedule for the next talks during today's dialogue and clearly stated our position that these negotiations are 'all-or-nothing.' We urged management to approach the talks with the understanding that 'if the next negotiations break down, there will be no further dialogue.'"

The union's policy is to sequentially go on strike if the negotiations starting on the 3rd of next month ultimately fail.

Regarding the union's stance, management stated, "We plan to faithfully participate in the upcoming negotiations."

Previously, after mediation with management broke down on March 23, the Samsung Biologics union staged a partial strike in late April followed by a full strike from May 1 to 5. Since then, it has continued a lawful struggle by refusing overtime and holiday work.

In addition, the union had planned to launch a second general strike for three weeks starting on the 26th of this month, but postponed the strike immediately following a court ruling that expanded restrictions on industrial action.

(Photo: Yonhap News)
※ Please note: This article was translated by AI and may contain errors.
Copyright Ⓒ SBS & SBSi. All rights reserved.
Copying, redistribution, and unauthorized use in AI training are strictly prohibited.

Most Read